Scleroderma Diagnostics and Therapeutics Market by Drug Class (Immunosuppressive Agents, Corticosteroids, Endothelin Receptor Agonists, Calcium Channel Blockers, Chelating Agents, PDE-5 Inhibitors, H2 Blockers, Prostacyclin Analogues, ACE Inhibitors, and Proton Pump Inhibitors), by Indication (Systemic and Localized), and by Diagnostic Test Type (Imaging Techniques, Skin Biopsy, Electrocardiogram and Echocardiogram, Pulmonary Function Tests, and Blood Test): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Global scleroderma diagnostics and therapeutics market expected to generate revenue of around USD 3,165.85 million by end of 2024, growing at a CAGR of around 10.21% between 2018 and 2024. Scleroderma is an autoimmune condition that is characterized by hard and thickened skin along with blood vessel problems.

Request Brochure Request Discount

10-Sep-2018 | Number of pages: 110 | Report Code: ZMR-3321 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the scleroderma diagnostics and therapeutics market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the scleroderma diagnostics and therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the scleroderma diagnostics and therapeutics market on a global as well as regional level.

In order to give the users of this report a comprehensive view of the scleroderma diagnostics and therapeutics market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein segmental segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Scleroderma Diagnostics and Therapeutics Market

The report provides company market share analysis in order to give a broader overview of the key players in the scleroderma diagnostics and therapeutics market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new drug class launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the scleroderma diagnostics and therapeutics market on the global and regional basis. 

The study provides a decisive view of the scleroderma diagnostics and therapeutics market by segmenting the market based on drug class, indication, diagnostic test type, and regions. The segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. The drug class segment has been segmented into immunosuppressive agents, corticosteroids, endothelin receptor agonists, calcium channel blockers, chelating agents, PDE-5 inhibitors, H2 blockers, prostacyclin analogs, ACE inhibitors, and proton pump inhibitors. Based on the indication, scleroderma diagnostics and therapeutics market have been segmented into systemic and localized. Based on diagnostic test type, scleroderma diagnostics and therapeutics market have been segmented into imaging techniques, skin biopsy, electrocardiogram and echocardiogram, pulmonary function tests, and blood test.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further bifurcation into major countries including the U.S. Canada, Germany, France, the UK, China, Japan, India, and Brazil. This segmentation includes demand for scleroderma diagnostics and therapeutics based on individual segment and applications in all the regions and countries.

The report also includes detailed profiles of end players such as Bayer AG, Allergan, Inc., Active Biotech AB, BioLineRx, Ltd., Digna Biotech, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Vida Therapeutics Inc., Angion Biomedica Corp., Daval International Ltd., Corbus Pharmaceuticals, Inc., and F. Hoffmann-La Roche Ltd. among others.

This report segments the global scleroderma diagnostics and therapeutics market as follows:

Global Scleroderma Diagnostics and Therapeutics Market: By Drug Class

  • Immunosuppressive Agents
  • Corticosteroids
  • Endothelin Receptor Agonists
  • Calcium Channel Blockers
  • Chelating Agents
  • PDE-5 Inhibitors
  • H2 Blockers
  • Prostacyclin Analogues
  • ACE Inhibitors
  • Proton Pump Inhibitors

Global Scleroderma Diagnostics and Therapeutics Market: By Indication

  • Systemic
  • Localized

Global Scleroderma Diagnostics and Therapeutics Market: By Diagnostic Test Type

  • Imaging Techniques
  • Skin Biopsy
  • Electrocardiogram and Echocardiogram
  • Pulmonary Function Tests
  • Blood Test

Global Scleroderma Diagnostics and Therapeutics Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports

U.S. Healthcare Transportation Services Market By Type (Medical Transportation (Medical End-Users, Incubator Transport, Mobile Treatment Facilities, and Patient Transport) and Non-Medical Transportation (Mailroom Services, Event Covers and Others)) and By End-Users (Private Paying Customers, Hospitals, Medical Centers, Nursing Care Facilities, and Airport Shuttle): U.S. Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2026

Oct-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3455 | Report Format:

The report analyzes and forecasts the healthcare transportation services market in the U.S. on the country level. The study offers past data for 2016 and 2017 along with forecast from 2018 to 2026 based on revenue (USD Billion). Assessment of healthcare transportation services market dynamics give...Read More

Peptide Therapeutics Market by Route of Administration (Parenteral, Oral, and Others), by Type (Innovative and Generic), by Type of Manufacturers (In-house and Outsourced), by Type of Molecule (Vasopressin, Somatostatin, Calcitonin, Immunopeptide, Natriuretic, and Others), by Technology (Liquid Phase, Solid Phase, and Hybrid Phase), and by Application (Cancer, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Infectious Disease, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Oct-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3439 | Report Format:

The report covers forecast and analysis for the peptide therapeutics market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the peptide therape...Read More

Cognitive and Memory Enhancer Drugs Market by Drug Type (Aricept, Razadyne, Namenda, Exelon, Provigil, Ritalin, Adderall, and others) and Application (Disease Treatment, Academic Performance, Athletic Performance and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 –2024

Oct-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3429 | Report Format:

The report covers forecast and analysis for the cognitive and memory enhancer drugs market on a global and regional level. The study provides historical data from 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints ...Read More

Connected Healthcare Market by Function (Telemedicine, Home Monitoring, Assisted Living, and Clinical Monitoring), by Type (e-Prescription, mHealth Services, and mHealth Devices), and Application (Diagnosis & Treatment, Monitoring Applications, Education & Awareness, Wellness & Prevention, Healthcare Management, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Oct-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3417 | Report Format:

The report covers forecast and analysis for the connected healthcare market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the connected healthcare ma...Read More

Kidney Stones Management Market by Diagnostics (Computed Tomography Scan, Abdominal X-ray, Ultrasound, Intravenous Pyelography, Abdominal MRI, and Others), by Type (Calcium Oxalate, Uric Acid, Calcium Phosphate, Cysteine, and Struvite), and by Treatment (Extracorporeal shock wave lithotripsy, Percutaneous Nephrolithotomy, Ureteroscopy, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Oct-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3412 | Report Format:

The report covers forecast and analysis for the kidney stones management market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the kidney stones manag...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.